drugset / Trial / NCT05024526

Protective Effects of Edaravone Dexborneol

NCT05024526

Unknown 80 enrolled Lili Cao
RandomizedParallel-groupSingle-blindTreatment

Summary

The patients of acute ischemic stroke were divided into two groups, edaravone dexborneol treatment group and edaravone treatment group. The purpose of this study was to observe the changes of imaging and the improvement of NIHSS and mRS in different groups.

Timeline

Start
2021-04-01
Primary completion
2022-12-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Edaravone Unknown
Subject Edaravone Dexborneol Unknown

Indications